Casdin-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
44
Total Value
1223806401
Accession Number
0000919574-25-003248
Form Type
13F-HR
Manager Name
Casdin-Capital
Data Enrichment
95% identified
42 identified2 unidentified

Holdings

44 positions
Manager:
Search and click to pin securities to the top
Page 1 of 3
GeneDx Holdings Corp.
Shares:3.5M
Value:$310.6M
BIOLIFE SOLUTIONS INC
Shares:8.7M
Value:$198.9M
Revolution Medicines, Inc.
Shares:3.7M
Value:$130.8M
STANDARD BIOTOOLS INC.
Shares:76.1M
Value:$82.2M
Avidity Biosciences, Inc.
Shares:2.0M
Value:$60.4M
Sarepta Therapeutics, Inc.
Shares:900.8K
Value:$57.5M
ILLUMINA, INC.
Shares:595.0K
Value:$47.2M
ALNYLAM PHARMACEUTICALS, INC.
Shares:120.0K
Value:$32.4M
Blueprint Medicines Corp
Shares:326.4K
Value:$28.9M
Beam Therapeutics Inc.
Shares:1.4M
Value:$27.8M
Relay Therapeutics, Inc.
Shares:9.1M
Value:$23.8M
CODEXIS, INC.
Shares:8.1M
Value:$21.8M
Verve Therapeutics, Inc.
Shares:4.0M
Value:$18.3M
EXACT SCIENCES CORP
Shares:405.0K
Value:$17.5M
Neurogene Inc.
Shares:1.3M
Value:$15.2M
Intellia Therapeutics, Inc.
Shares:2.0M
Value:$14.2M
Denali Therapeutics Inc.
Shares:990.0K
Value:$13.5M
Structure Therapeutics Inc.
Shares:700.0K
Value:$12.1M
07725L102
Shares:40.0K
Value:$10.9M
Guardant Health, Inc.
Shares:250.0K
Value:$10.7M